AgomAb Therapeutics NV American Depositary Shares (AGMB) is a publicly traded the market company. As of May 21, 2026, AGMB trades at $10.69 with a market cap of $520.06M and a P/E ratio of 0.00. AGMB moved +0.76% today. Year to date, AGMB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $9.00 to $17.45. Analyst consensus is strong buy with an average price target of $32.00. Rallies surfaces AGMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own AGMB include Redmile Group. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AgomAb Therapeutics NV American Depositary Shares.
| Metric | Value |
|---|---|
| Price | $10.69 |
| Market Cap | $520.06M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.45 |
| 52-Week Low | $9.00 |
| Volume | 12 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover AGMB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.00.